{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T17:33:04Z","timestamp":1793727184247,"version":"4.6.1"},"reference-count":65,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T00:00:00Z","timestamp":1767571200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100013064","name":"Key Research and Development Program of Jiangxi Province","doi-asserted-by":"publisher","award":["20203BBG73063"],"award-info":[{"award-number":["20203BBG73063"]}],"id":[{"id":"10.13039\/501100013064","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100020784","name":"Gannan Medical University","doi-asserted-by":"publisher","award":["QD201910"],"award-info":[{"award-number":["QD201910"]}],"id":[{"id":"10.13039\/501100020784","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004479","name":"Natural Science Foundation of Jiangxi Province","doi-asserted-by":"publisher","award":["20252BAC250108"],"award-info":[{"award-number":["20252BAC250108"]}],"id":[{"id":"10.13039\/501100004479","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004479","name":"Natural Science Foundation of Jiangxi Province","doi-asserted-by":"publisher","award":["jxsq2019101064"],"award-info":[{"award-number":["jxsq2019101064"]}],"id":[{"id":"10.13039\/501100004479","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82360701"],"award-info":[{"award-number":["82360701"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100017610","name":"Shenzhen Science and Technology Innovation Program","doi-asserted-by":"publisher","award":["JCYJ20220818103017036"],"award-info":[{"award-number":["JCYJ20220818103017036"]}],"id":[{"id":"10.13039\/501100017610","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Structural Biology: X"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.yjsbx.2026.100143","type":"journal-article","created":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T08:06:58Z","timestamp":1767686818000},"page":"100143","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Structural insights of the coronavirus main protease in complex with the non-covalent inhibitor CCF0058981"],"prefix":"10.1016","volume":"13","author":[{"given":"Pei","family":"Zeng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuelan","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenwen","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.yjsbx.2026.100143_b0005","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.softx.2015.06.001","article-title":"GROMACS: high performance molecular simulations through multi-level parallelism from laptops to supercomputers","volume":"1\u20132","author":"Abraham","year":"2015","journal-title":"SoftwareX"},{"key":"10.1016\/j.yjsbx.2026.100143_b0010","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1107\/S0907444909052925","article-title":"PHENIX: a comprehensive Python-based system for macromolecular structure solution","volume":"66","author":"Adams","year":"2010","journal-title":"Acta Crystallogr. Sect. D, Biol. Crystallogr."},{"key":"10.1016\/j.yjsbx.2026.100143_b0015","doi-asserted-by":"crossref","first-page":"3601","DOI":"10.1021\/acs.jcim.3c00282","article-title":"Targeting SARS-CoV-2 main protease: a successful story guided by an in silico drug repurposing approach","volume":"63","author":"Ambrosio","year":"2023","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.yjsbx.2026.100143_b0020","doi-asserted-by":"crossref","first-page":"3684","DOI":"10.1063\/1.448118","article-title":"Molecular dynamics with coupling to an external bath","volume":"81","author":"Berendsen","year":"1984","journal-title":"J. Chem. Phys."},{"key":"10.1016\/j.yjsbx.2026.100143_b0025","doi-asserted-by":"crossref","first-page":"138","DOI":"10.3390\/e16010138","article-title":"Time integrators for molecular dynamics","volume":"16","author":"Bou-Rabee","year":"2014","journal-title":"Entropy"},{"key":"10.1016\/j.yjsbx.2026.100143_b0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmc.2025.118247","article-title":"Recent breakthroughs in synthetic small molecules targeting SARS-CoV-2 M(pro) from 2022 to 2024","volume":"128","author":"Braconi","year":"2025","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.yjsbx.2026.100143_b0035","doi-asserted-by":"crossref","first-page":"575","DOI":"10.4155\/fmc-2020-0262","article-title":"De novo design of new chemical entities for SARS-CoV-2 using artificial intelligence","volume":"13","author":"Bung","year":"2021","journal-title":"Future Med. Chem."},{"key":"10.1016\/j.yjsbx.2026.100143_b0040","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1056\/NEJMc2206449","article-title":"Rebound of SARS-CoV-2 infection after nirmatrelvir-ritonavir treatment","volume":"387","author":"Charness","year":"2022","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.yjsbx.2026.100143_b0045","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1107\/S0907444909042073","article-title":"MolProbity: all-atom structure validation for macromolecular crystallography","volume":"66","author":"Chen","year":"2010","journal-title":"Acta crystallogr. Sect. D, Biol. Crystallogr."},{"key":"10.1016\/j.yjsbx.2026.100143_b0050","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1021\/acs.jcim.1c00851","article-title":"High-throughput virtual screening and validation of a SARS-CoV-2 main protease noncovalent inhibitor","volume":"62","author":"Clyde","year":"2022","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.yjsbx.2026.100143_b0055","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1056\/NEJMsb2104756","article-title":"SARS-CoV-2 variants in patients with immunosuppression","volume":"385","author":"Corey","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.yjsbx.2026.100143_b0060","first-page":"2285","article-title":"Protein crystallization for X-ray crystallography","author":"Dessau","year":"2011","journal-title":"J. Vis. Exp.: JoVE"},{"key":"10.1016\/j.yjsbx.2026.100143_b0065","doi-asserted-by":"crossref","DOI":"10.1103\/PhysRevE.104.025304","article-title":"Steepest-descent algorithm for simulating plasma-wave caustics via metaplectic geometrical optics","volume":"104","author":"Donnelly","year":"2021","journal-title":"Phys. Rev. E"},{"key":"10.1016\/j.yjsbx.2026.100143_b0070","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1038\/s41586-023-06609-0","article-title":"Molecular mechanisms of SARS-CoV-2 resistance to nirmatrelvir","volume":"622","author":"Duan","year":"2023","journal-title":"Nature"},{"key":"10.1016\/j.yjsbx.2026.100143_b0075","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1107\/S0907444910007493","article-title":"Features and development of coot","volume":"66","author":"Emsley","year":"2010","journal-title":"Acta crystallogr. Sect. D, Biol. Crystallogr."},{"key":"10.1016\/j.yjsbx.2026.100143_b0080","doi-asserted-by":"crossref","first-page":"8577","DOI":"10.1063\/1.470117","article-title":"A smooth particle mesh ewald method","volume":"103","author":"Essmann","year":"1995","journal-title":"J. Chem. Phys."},{"key":"10.1016\/j.yjsbx.2026.100143_b0085","doi-asserted-by":"crossref","first-page":"e914","DOI":"10.1002\/cpz1.914","article-title":"Improved culture methods for human coronaviruses HCoV-OC43, HCoV-229E, and HCoV-NL63","volume":"3","author":"Fausto","year":"2023","journal-title":"Current Protocols"},{"key":"10.1016\/j.yjsbx.2026.100143_b0090","doi-asserted-by":"crossref","unstructured":"Fehr, A.R., Perlman, S., 2015. Coronaviruses: an overview of their replication and pathogenesis. Methods in molecular biology (Clifton, N.J.) 1282, 1\u201323.","DOI":"10.1007\/978-1-4939-2438-7_1"},{"key":"10.1016\/j.yjsbx.2026.100143_b0095","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1517\/17460441.2015.1032936","article-title":"The MM\/PBSA and MM\/GBSA methods to estimate ligand-binding affinities","volume":"10","author":"Genheden","year":"2015","journal-title":"Expert Opin. Drug Discov."},{"key":"10.1016\/j.yjsbx.2026.100143_b0100","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/S0140-6736(24)01136-X","article-title":"Long COVID: a clinical update","volume":"404","author":"Greenhalgh","year":"2024","journal-title":"Lancet (london, England)"},{"key":"10.1016\/j.yjsbx.2026.100143_b0105","doi-asserted-by":"crossref","first-page":"99261","DOI":"10.1007\/s11356-023-25714-1","article-title":"Impacts of COVID-19 pandemic on environment, society, and food security","volume":"30","author":"Hammad","year":"2023","journal-title":"Environ. Sci. Pollut. Res. Int."},{"key":"10.1016\/j.yjsbx.2026.100143_b0110","doi-asserted-by":"crossref","unstructured":"Hamre, D., Procknow, J.J., 1966. A new virus isolated from the human respiratory tract. Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.) 121, 190-193.","DOI":"10.3181\/00379727-121-30734"},{"key":"10.1016\/j.yjsbx.2026.100143_b0115","doi-asserted-by":"crossref","first-page":"2880","DOI":"10.1021\/acs.jmedchem.1c00598","article-title":"Structure-based optimization of ML300-derived, noncovalent inhibitors targeting the severe acute respiratory syndrome coronavirus 3CL protease (SARS-CoV-2 3CL(pro))","volume":"65","author":"Han","year":"2022","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.yjsbx.2026.100143_b0120","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1038\/s41591-022-01882-4","article-title":"Drivers of adaptive evolution during chronic SARS-CoV-2 infections","volume":"28","author":"Harari","year":"2022","journal-title":"Nat. Med."},{"key":"10.1016\/j.yjsbx.2026.100143_b0125","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.bbrc.2022.11.017","article-title":"De novo design of dual-target JAK2, SMO inhibitors based on deep reinforcement learning, molecular docking and molecular dynamics simulations","volume":"638","author":"He","year":"2023","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.yjsbx.2026.100143_b0130","doi-asserted-by":"crossref","unstructured":"Heilmann, E., Costacurta, F., Moghadasi, S.A., Ye, C., Pavan, M., Bassani, D., Volland, A., Ascher, C., Weiss, A.K.H., Bante, D., Harris, R.S., Moro, S., Rupp, B., Martinez-Sobrido, L., von Laer, D., 2023. SARS-CoV-2 3CL(pro) mutations selected in a VSV-based system confer resistance to nirmatrelvir, ensitrelvir, and GC376. Sci. Transl. Med. 15, eabq7360.","DOI":"10.1126\/scitranslmed.abq7360"},{"key":"10.1016\/j.yjsbx.2026.100143_b0135","doi-asserted-by":"crossref","first-page":"e151","DOI":"10.1002\/mco2.151","article-title":"The SARS-CoV-2 main protease (M(pro)): Structure, function, and emerging therapies for COVID-19","volume":"3","author":"Hu","year":"2022","journal-title":"MedComm"},{"key":"10.1016\/j.yjsbx.2026.100143_b0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.antiviral.2025.106118","article-title":"M49L and other drug resistance mutations emerging in individuals after administration of ensitrelvir in Japanese clinical settings","volume":"236","author":"Inoue","year":"2025","journal-title":"Antiviral Res."},{"key":"10.1016\/j.yjsbx.2026.100143_b0145","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1038\/s41541-023-00756-1","article-title":"Systematic review and meta-analysis of the factors affecting waning of post-vaccination neutralizing antibody responses against SARS-CoV-2","volume":"8","author":"Jacobsen","year":"2023","journal-title":"NPJ Vacc."},{"key":"10.1016\/j.yjsbx.2026.100143_b0150","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbrc.2023.149352","article-title":"Crystal structure of SARS-CoV-2 main protease (M(pro)) mutants in complex with the non-covalent inhibitor CCF0058981","volume":"692","author":"Jiang","year":"2024","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.yjsbx.2026.100143_b0155","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1038\/s41392-023-01482-9","article-title":"Discovery of novel non-peptidic and non-covalent small-molecule 3CL(pro) inhibitors as potential candidate for COVID-19 treatment","volume":"8","author":"Jiang","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.yjsbx.2026.100143_b0160","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1038\/s41586-020-2223-y","article-title":"Structure of Mpro from SARS-CoV-2 and discovery of its inhibitors","volume":"582","author":"Jin","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.yjsbx.2026.100143_b0165","doi-asserted-by":"crossref","first-page":"151","DOI":"10.18071\/isz.77.0151","article-title":"Cognitive impairment in long-COVID","volume":"77","author":"Julide","year":"2024","journal-title":"Ideggyogyaszati Szemle"},{"key":"10.1016\/j.yjsbx.2026.100143_b0170","doi-asserted-by":"crossref","first-page":"216","DOI":"10.3389\/fpubh.2020.00216","article-title":"COVID-19: emergence, spread, possible treatments, and global burden","volume":"8","author":"Keni","year":"2020","journal-title":"Front. Public Health"},{"key":"10.1016\/j.yjsbx.2026.100143_b0175","doi-asserted-by":"crossref","first-page":"e2282","DOI":"10.1002\/rmv.2282","article-title":"An overview on the seven pathogenic human coronaviruses","volume":"32","author":"Kesheh","year":"2022","journal-title":"Rev. Med. Virol."},{"key":"10.1016\/j.yjsbx.2026.100143_b0180","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2023.104886","article-title":"Contribution of the catalytic dyad of SARS-CoV-2 main protease to binding covalent and noncovalent inhibitors","volume":"299","author":"Kovalevsky","year":"2023","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.yjsbx.2026.100143_b0185","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/j.scib.2020.10.018","article-title":"Crystal structure of SARS-CoV-2 main protease in complex with the natural product inhibitor shikonin illuminates a unique binding mode","volume":"66","author":"Li","year":"2021","journal-title":"Sci. Bull."},{"key":"10.1016\/j.yjsbx.2026.100143_b0190","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.115772","article-title":"Structure and function of SARS-CoV and SARS-CoV-2 main proteases and their inhibition: a comprehensive review","volume":"260","author":"Li","year":"2023","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.yjsbx.2026.100143_b0195","doi-asserted-by":"crossref","first-page":"1950","DOI":"10.1002\/prot.22711","article-title":"Improved side-chain torsion potentials for the Amber ff99SB protein force field","volume":"78","author":"Lindorff-Larsen","year":"2010","journal-title":"Proteins"},{"key":"10.1016\/j.yjsbx.2026.100143_b0200","series-title":"Encyclopedia of Virology (fourth Edition)","first-page":"428","article-title":"Human coronavirus-229E, -OC43, -NL63, and -HKU1 (coronaviridae)","author":"Liu","year":"2021"},{"key":"10.1016\/j.yjsbx.2026.100143_b0205","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1107\/S0021889807021206","article-title":"Phaser crystallographic software","volume":"40","author":"McCoy","year":"2007","journal-title":"J. Appl. Cryst."},{"key":"10.1016\/j.yjsbx.2026.100143_b0210","article-title":"Potency, safety, and pharmacokinetic profiles of potential inhibitors targeting SARS-CoV-2 main protease","volume":"11","author":"Mengist","year":"2020","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.yjsbx.2026.100143_b0215","doi-asserted-by":"crossref","first-page":"2495","DOI":"10.1016\/j.jksus.2020.04.004","article-title":"Biological and epidemiological trends in the prevalence and mortality due to outbreaks of novel coronavirus COVID-19","volume":"32","author":"Meo","year":"2020","journal-title":"J. King Saud Univ. Sci."},{"key":"10.1016\/j.yjsbx.2026.100143_b0220","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.ade8778","article-title":"Transmissible SARS-CoV-2 variants with resistance to clinical protease inhibitors","volume":"9","author":"Moghadasi","year":"2023","journal-title":"Sci. Adv."},{"key":"10.1016\/j.yjsbx.2026.100143_b0225","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1093\/cid\/ciac933","article-title":"Efficacy and safety of ensitrelvir in patients with mild-to-moderate coronavirus disease 2019: the phase 2b part of a randomized, placebo-controlled, phase 2\/3 study","volume":"76","author":"Mukae","year":"2023","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.yjsbx.2026.100143_b0230","doi-asserted-by":"crossref","DOI":"10.1177\/20499361251321724","article-title":"Ensitrelvir as a novel treatment option for mild-to-moderate COVID-19: a narrative literature review","volume":"12","author":"Mukae","year":"2025","journal-title":"Therapeut. Adv. Infect. Disease"},{"key":"10.1016\/j.yjsbx.2026.100143_b0235","doi-asserted-by":"crossref","DOI":"10.1093\/toxres\/tfae045","article-title":"The global impact of COVID-19: a comprehensive analysis of its effects on various aspects of life","volume":"13","author":"Naveed","year":"2024","journal-title":"Toxicol. Res."},{"key":"10.1016\/j.yjsbx.2026.100143_b0240","doi-asserted-by":"crossref","first-page":"3354","DOI":"10.1021\/ct2002732","article-title":"Comparison of tetrahedral order, liquid state anomalies, and hydration behavior of mTIP3P and TIP4P water models","volume":"7","author":"Nayar","year":"2011","journal-title":"J. Chem. Theory Comput."},{"key":"10.1016\/j.yjsbx.2026.100143_b0245","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1126\/science.abl4784","article-title":"An oral SARS-CoV-2 M(pro) inhibitor clinical candidate for the treatment of COVID-19","volume":"374","author":"Owen","year":"2021","journal-title":"Science (New York, N.Y.)"},{"key":"10.1016\/j.yjsbx.2026.100143_b0250","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1007\/s00894-010-0650-7","article-title":"An improved generalized AMBER force field (GAFF) for urea","volume":"16","author":"Ozpinar","year":"2010","journal-title":"J. Mol. Model."},{"key":"10.1016\/j.yjsbx.2026.100143_b0255","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1021\/acscentsci.1c00258","article-title":"Potent SARS-CoV-2 direct-acting antivirals provide an important complement to COVID-19 vaccines","volume":"7","author":"Pelly","year":"2021","journal-title":"ACS Cent. Sci."},{"issue":"86","key":"10.1016\/j.yjsbx.2026.100143_b0260","doi-asserted-by":"crossref","first-page":"5343","DOI":"10.1097\/MS9.0000000000002374","article-title":"COVID-19: vaccination, therapeutics and a review of the science and public health","volume":"2012","author":"Shah","year":"2024","journal-title":"Ann. Med. Surg."},{"key":"10.1016\/j.yjsbx.2026.100143_b0265","doi-asserted-by":"crossref","DOI":"10.1093\/molbev\/msad089","article-title":"Adaptive evolution of the spike protein in coronaviruses","volume":"40","author":"Tang","year":"2023","journal-title":"Mol. Biol. Evol."},{"key":"10.1016\/j.yjsbx.2026.100143_b0270","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/j.ijbiomac.2021.01.076","article-title":"Trends and strategies to combat viral infections: a review on FDA approved antiviral drugs","volume":"172","author":"Tompa","year":"2021","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.yjsbx.2026.100143_b0275","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmcl.2020.127377","article-title":"The SARS-CoV-2 main protease as drug target","volume":"30","author":"Ullrich","year":"2020","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.yjsbx.2026.100143_b0280","doi-asserted-by":"crossref","first-page":"6499","DOI":"10.1021\/acs.jmedchem.2c00117","article-title":"Discovery of S-217622, a noncovalent oral SARS-CoV-2 3CL protease inhibitor clinical candidate for treating COVID-19","volume":"65","author":"Unoh","year":"2022","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.yjsbx.2026.100143_b0285","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1002\/jcc.20291","article-title":"GROMACS: fast, flexible, and free","volume":"26","author":"Van Der Spoel","year":"2005","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.yjsbx.2026.100143_b0290","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1038\/s42003-025-07929-9","article-title":"Inhibitory efficacy and structural insights of Bofutrelvir against SARS-CoV-2 M(pro) mutants and MERS-CoV M(pro)","volume":"8","author":"Wang","year":"2025","journal-title":"Commun. Biol."},{"key":"10.1016\/j.yjsbx.2026.100143_b0295","doi-asserted-by":"crossref","first-page":"23555","DOI":"10.1039\/D3CP03828A","article-title":"The molecular mechanism of non-covalent inhibitor WU-04 targeting SARS-CoV-2 3CLpro and computational evaluation of its effectiveness against mainstream coronaviruses","volume":"25","author":"Wu","year":"2023","journal-title":"Phys. Chem. Chem. Phys."},{"key":"10.1016\/j.yjsbx.2026.100143_b0300","doi-asserted-by":"crossref","first-page":"797","DOI":"10.3390\/biom14070797","article-title":"Inhibitors of SARS-CoV-2 main protease (Mpro) as anti-coronavirus agents","volume":"14","author":"Zag\u00f3rska","year":"2024","journal-title":"Biomolecules"},{"key":"10.1016\/j.yjsbx.2026.100143_b0305","first-page":"409","volume":"vol. 368","author":"Zhang","year":"2020","journal-title":"Crystal Structure of SARS-CoV-2 Main Protease Provides a Basis for Design of Improved \u03b1-Ketoamide Inhibitors"},{"key":"10.1016\/j.yjsbx.2026.100143_b0310","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.cell.2020.03.035","article-title":"A genomic perspective on the origin and emergence of SARS-CoV-2","volume":"181","author":"Zhang","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.yjsbx.2026.100143_b0315","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1007\/s11427-020-1791-3","article-title":"Structure of SARS-CoV-2 main protease in the apo state","volume":"64","author":"Zhou","year":"2021","journal-title":"Sci. China Life Sci."},{"key":"10.1016\/j.yjsbx.2026.100143_b0320","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1186\/s12931-020-01479-w","article-title":"From SARS and MERS to COVID-19: a brief summary and comparison of severe acute respiratory infections caused by three highly pathogenic human coronaviruses","volume":"21","author":"Zhu","year":"2020","journal-title":"Respir. Res."},{"key":"10.1016\/j.yjsbx.2026.100143_b0325","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1099\/0022-1317-81-4-853","article-title":"Virus-encoded proteinases and proteolytic processing in the Nidovirales","volume":"81","author":"Ziebuhr","year":"2000","journal-title":"J. Gen. Virol."}],"container-title":["Journal of Structural Biology: X"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590152426000012?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590152426000012?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T08:30:26Z","timestamp":1782203426000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2590152426000012"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":65,"alternative-id":["S2590152426000012"],"URL":"https:\/\/doi.org\/10.1016\/j.yjsbx.2026.100143","relation":{},"ISSN":["2590-1524"],"issn-type":[{"value":"2590-1524","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Structural insights of the coronavirus main protease in complex with the non-covalent inhibitor CCF0058981","name":"articletitle","label":"Article Title"},{"value":"Journal of Structural Biology: X","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yjsbx.2026.100143","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"100143"}}